Infectious Diseases

Study determines how many patients hospitalized with COVID-19 had contraindications to nirmatrelvir–ritonavir and would have required an alternate outpatient treatment.

With the many students coming into his clinic for immunizations, Dr. Robert Dickson encounters an interesting TB skin test result.

Gene activity indicates greater damage to the cells lining the nose; correlates to longer PICU stays.

The federal agency says however that there are eight other drug producers offering medication with amoxicillin that are not currently reporting any issues with supply.

There’s no need for a skin test or special vaccine.

Health Canada noted the booster dose has a similar safety profile to previous iterations of Spikevax boosters.

Evusheld was only recently approved in Canada as a treatment for mild to moderate COVID-19.

Public Health Ontario says COVID-19 activity in the province is generally stable, though it has been gradually increasing since early September.